Propanc Biopharma (PPCB) Research & Development (2010 - 2025)
Propanc Biopharma (PPCB) posted Research & Development of $625,477 for FY2026 (year ended Jun 30, 2026), up 179.6% from $223,721 in FY2025.
Powered by 
Analysis
Propanc Biopharma (PPCB) Research & Development (2010 - 2025) Analysis & Trends
Since FY2011, Propanc Biopharma has reported Research & Development for 16 fiscal years.
- Annual Research & Development shows a five-year compound annual growth rate of 22.0% (FY2021 to FY2026).
- The FY2026 figure stands as the highest annual Research & Development since FY2018.
- Business Quant data shows PPCB's Research & Development at $223,721 in FY2025 (-9.8%), $248,102 in FY2024 (+0.1%), $247,919 in FY2023 (-3.2%) and $256,052 in FY2022 (+10.9%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,140.41 Bn | 1,108.99 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 618.57 Bn | 537.10 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 509.95 Bn | 483.06 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 366.63 Bn | 321.01 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 298.47 Bn | 262.46 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 263.21 Bn | 236.89 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 236.71 Bn | 192.11 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 193.05 Bn | 167.25 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 171.45 Bn | 118.10 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Propanc Biopharma | 357,002.35 | -1.65 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 19,961.00 |
| Sep 30, 2025 | 60,201.00 |
| Jun 30, 2025 | 53,522.00 |
| Mar 31, 2025 | 54,097.00 |
| Dec 31, 2024 | 54,388.00 |
| Sep 30, 2024 | 61,714.00 |
| Jun 30, 2024 | 52,390.00 |
| Mar 31, 2024 | 65,448.00 |
| Dec 31, 2023 | 114,022.00 |
| Sep 30, 2023 | 16,242.00 |
| Jun 30, 2023 | 5,696.00 |
| Mar 31, 2023 | 66,020.00 |
| Dec 31, 2022 | 74,878.00 |
| Sep 30, 2022 | 101,325.00 |
| Jun 30, 2022 | 108,350.00 |
| Mar 31, 2022 | 50,395.00 |
| Dec 31, 2021 | 50,753.00 |
| Sep 30, 2021 | 46,554.00 |
| Jun 30, 2021 | 85,058.00 |
| Mar 31, 2021 | 44,887.00 |
API Access
Propanc Biopharma Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=PPCB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "PPCB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=PPCB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();